Composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid

The technology of hydroxynicotinamide group and p-hydroxyphenyl group is applied in the field of synthesis of pharmaceutical intermediates, which can solve the problems of cumbersome operation and a large amount of waste water, and achieves the effects of small waste water volume, easy treatment and simple process operation.

Inactive Publication Date: 2011-02-16
山东众诚生物医药股份有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This process will produce a large amount of waste water due to the esterification of HPG and the hydrolysis of the final product ester, and the operation is cumbersome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid
  • Composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid
  • Composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1: synthetic reaction route is as follows:

[0039]

[0040] (1) Suspend 13.36g of HPG in 120ml of dichloromethane as an organic solvent, cool to 10°C, then add 27g of trimethylchlorosilane (silicon esterification agent) at one time, and then slowly add organic solvent at 15°C to 20°C Base 24.24g of triethylamine, keep stirring at the same temperature for 1.5 hours to obtain HPG silicon esterification solution.

[0041] (2) Take 15g of MHPA and suspend it in 140ml of methylene chloride, and use the MHPA acyl chloride prepared by the conventional acyl chloride preparation method.

[0042] (3) Control the temperature at 15°C to 18°C, slowly add MHPA acid chloride dropwise to the HPG silicon esterification solution in step (1), keep the same temperature for 1.5 hours, then add 260ml deionized water, and use 10% NaOH The pH of the solution was adjusted to 7.1. Still layering.

[0043](4) Decolorize the water layer with activated carbon, remove the activated...

Embodiment 2

[0045] As described in Example 1, the difference is that dichloroethane is used as the organic solvent, and the result is 20.3 grams of D-α-(6-methyl-4-hydroxynicotinamide) p-hydroxyphenylacetic acid, yield 84.02% .

Embodiment 3

[0047] As described in Example 1, the difference is that the silicon esterification agent uses diethylmethylchlorosilane to obtain 19 grams of D-α-(6-methyl-4-hydroxynicotinamide) p-hydroxyphenylacetic acid crystals , yield 78.64%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid, which includes the steps of using the acyl chloride of 4-hydroxy-6-methylnicotinic acid to directly acylate and esterify D-hydroxyphenylglycine, using water to remove the estersil of an acylation product and directly obtaining an objective product D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid. Compared with the method of composing D-hydroxyphenylglycine into alkane ester or salt at first, the composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid simplifies the operation and is suitable for large-scale production.

Description

technical field [0001] The invention belongs to the technical field of synthesis of pharmaceutical intermediates, and in particular relates to a synthesis method of D-α-(6-methyl-4-hydroxynicotinamide) p-hydroxyphenylacetic acid, an intermediate of cephalosporin antibiotic cefpiramide. Background technique [0002] Cefpiramide is a third-generation cephalosporin jointly developed by Sumitomo and Yamanouchi, and cefpiramide sodium salt is used clinically. Its chemical name is (6R, 7R,)-7-[(R)-2-(4-hydroxy-6-methyl-3-pyridylcarboxamido)-2-(p-hydroxyphenyl)acetamido ]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4,2,0] Oct-2-ene-2-carboxylic acid sodium salt, CAS No: 74849-93-7, the structural formula is: [0003] [0004] This product was launched in Japan before 1985, due to its C 3 With a methyl tetrazolyl sulfur group in the position, C 7 There is a hydroxyphenylmethylpyridyl group at the position, thus greatly improving the antibacterial act...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D213/82
Inventor 李义丁伟达李勇
Owner 山东众诚生物医药股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap